Zoetis Interest Paid increased by 202.8% to $109.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 60.3%, from $68.00M to $109.00M. Over 4 years (FY 2021 to FY 2025), Interest Paid shows relatively stable performance with a 0.8% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase in interest paid relative to debt levels may signal rising borrowing costs or higher leverage, while a decrease may indicate debt reduction or refinancing at lower rates.
The total cash outflow for interest payments on debt obligations, typically disclosed as a supplemental item in the cash...
Essential for comparing the cost of capital and debt burden across peers in the pharmaceutical industry.
interest_paid| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $33.00M | $94.00M | $32.00M | $89.00M | $32.00M | $88.00M | $33.00M | $89.00M | $69.00M | $67.00M | $70.00M | $68.00M | $70.00M | $67.00M | $69.00M | $68.00M | $69.00M | $88.00M | $36.00M | $109.00M |
| QoQ Change | — | +184.8% | -66.0% | +178.1% | -64.0% | +175.0% | -62.5% | +169.7% | -22.5% | -2.9% | +4.5% | -2.9% | +2.9% | -4.3% | +3.0% | -1.4% | +1.5% | +27.5% | -59.1% | +202.8% |
| YoY Change | — | — | — | — | -3.0% | -6.4% | +3.1% | +0.0% | +115.6% | -23.9% | +112.1% | -23.6% | +1.4% | +0.0% | -1.4% | +0.0% | -1.4% | +31.3% | -47.8% | +60.3% |